reports
Yandex N.V. Announces First Quarter 2024 Financial Results
Yandex N.V. Yandex N.V. Announces First Quarter 2024 Financial Results 26-Apr-2024 / 12:00 MSK The issuer is solely responsible for the content of this announcement. Yandex N.V. Announces First Quarter 2024 Financial Results AMSTERDAM, the Netherlands, April 26, 2024 -- Yandex N.V. (NASDAQ: YNDX), a Dutch public limited company, today announced its unaudited financial results for the first quarter ended March 31, 2024. Q1 2024 Financial and Operational Highlights1,2 On February 5, 2024, we announced our binding agreement with a purchaser consortium to sell all of the ...
- Maria Vara
Median Technologies: reports Q1 2024 results
Median reconfirmed previously shared FY 2023 and reported Q1 2024 results this morning. FY 2023 sales were confirmed at EUR 22.2m representing a 7% drop vs. 2022, as iCRO business has been hampered by the COVID crisis in China. While the first three-quarter 2023 revenues were stable at ~5.6m per qu
- ABGSC Renewable Energy Research
- Olof Cederholm
Åsa Vilsson new CFO at Elanders
Åsa Vilsson new CFO at Elanders Åsa Vilsson has been appointed as the new CFO of Elanders. She most recently served as Vice President of Group Finance at Elanders and has been acting CFO since February 2024. Åsa will enter the role as CFO and member of Elanders’ Group Management today, April 26, 2024. Åsa has a broad background in accounting and a master’s degree in business and economics from Jönköping International Business School. I am very pleased that Åsa has chosen to accept the role as CFO and that we can fill such an important function internally, says Magnus Nilsson, President and...
Åsa Vilsson ny CFO på Elanders
Åsa Vilsson ny CFO på Elanders Åsa Vilsson har utsetts till ny CFO på Elanders. Hon kommer närmast från rollen som koncernredovisningsansvarig på Elanders och har sedan februari 2024 varit tillförordnad CFO. Åsa tillträder sin roll som CFO och medlem av Elanders koncernledning idag 26 april 2024. Åsa har en bred redovisningsbakgrund och en ekonomie magisterexamen vid Internationella Handelshögskolan i Jönköping. Jag är väldigt glad över att Åsa valt att tacka ja till rollen som CFO och att vi kan tillsätta en så viktig funktion internt, säger Magnus Nilsson, VD och koncernchef. Åsa Vilsso...
Meddelelse nr. 08/2024: Forløb af ordinær generalforsamling
Meddelelse nr. 08/2024: Forløb af ordinær generalforsamling Strategic Investments A/S (CVR nr. 71064719) afholdte fredag d. 26. april 2024 kl. 10:00 ordinær generalforsamling. Indkaldelse, dagsorden og de fuldstændige forslag fremgår af selskabsmeddelelse nr. 06/2024 af d. 4. april 2024. Bestyrelsen havde udpeget advokat Jens Ahrendt, Mazanti-Andersen Advokatpartnerselskab som dirigent. Dirigenten konstaterede, at generalforsamlingen var rettidigt varslet og beslutningsdygtig. Dagsordenspunkt 1-3Adm. dir. Jens Black gennemgik årets væsentligste begivenheder, redegjorde for selskabets ...
Moody's Ratings assigns definitive Aaa to Alandsbanken Abp CBA Covered...
Moody's Ratings (Moody's) has today assigned a definitive Aaa long-term ratings to the mortgage covered bonds ("covered bonds") issued by Alandsbanken Abp (or "Bank of Aland", "the Issuer", A2(cr), A3 Bank Deposits) which are governed by the new Finnish covered bond act. RATINGS RATIONALE A cove...
CRCAM du Languedoc: Archivage onde AMF réglementaire du rapport au tit...
CRCAM du Languedoc: Archivage onde AMF réglementaire du rapport au titre du pilier III au 31-12-2023 Bonjour, Sur demande de l'AMF, veuillez trouver en PJ pour archivage réglementaire le rapport au titre du PILIER 3 au 31-12-2023 de notre CRCAM du Languedoc. Ce document est à positionner dans ONDE: Informations réglementées continues / informations privilégiées / autres communiqués En vous remerciant par avance Pièce jointe
Net Asset Value(s)
Net Asset Value(s) WisdomTree Issuer plc – Daily Fund Prices 25-April-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc24/04/2024IE00BDVPNG1314054630USD845,390,073.4960.1503WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged24/04/2024IE00BFNNN2361662036EUR135,999,021.0681.8268WisdomTree Artificial Intelligence UCITS ETF - USD Acc25/04/2024IE00BDVPNG1314054630USD840,758,011.8659.8207WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged25/04/2024IE00BFNNN2361662036EUR135,740,932.7481.6715WisdomTree AT1 CoCo Bond UCITS ETF - GBP Hedged25/04/2024IE00BFNNN459171509GBP14,665...
Forløb af ekstraordinær generalforsamling fredag den 26. april 2024
Forløb af ekstraordinær generalforsamling fredag den 26. april 2024 SELSKABSMEDDELELSE A.P. Møller - Mærsk A/S – Forløb af ekstraordinær generalforsamling fredag den 26. april 2024 Den ekstraordinære generalforsamling i A.P. Møller - Mærsk A/S afholdtes fredag den 26. april 2024 som fuldstændig elektronisk generalforsamling i henhold til nedenstående dagsorden. Bestyrelsen havde udpeget advokat Niels Kornerup til dirigent. Dagsorden Gennemførsel af s...
Development of the Extraordinary General Meeting on Friday 26 April 20...
Development of the Extraordinary General Meeting on Friday 26 April 2024 ANNOUNCEMENT A.P. Møller - Mærsk A/S - Development of the Extraordinary General Meeting on Friday 26 April 2024 The Extraordinary General Meeting of A.P. Møller - Mærsk A/S took place on Friday 26 April 2024 as a completely electronic general meeting in accordance with the below agenda. The Board of Directors had appointed Niels Kornerup, attorney-at-law, as chair of the meeting. Agenda Completion of the demerger. The Genera...
- Pierre FerraguÊ
Infineon: Near-term downside priced in. Attractively valued for the lo...
As a follow-up to the work we published two weeks ago, which called for a downcycle in the auto semiconductor market, we review our expectations for Infineon. In summary, we expect Infineon to outperform the broader market, driven by a favorable exposure to xEVs and microcontroller share gains. We still see downside to expectations over the next 12 months, but from a stock perspective, we find the company attractively valued ahead of another leg of strong secular growth beyond this year.
- Emily Liu
Hybridan Research : Roquefort Therapeutics : Licensing deals and/or ot...
Roquefort Therapeutics today announced its audited results for the year ended 31 December 2023. The net loss was £1.7m (2022: loss of £1.6m) due to ongoing R&D and administrative expenses. As at 31 December 2023, the cash position was £0.5m (2022: £2.3m). Management aims to prepare at least one program for a Phase 1 clinical study. It is likely Roquefort will need to raise further funds (either through licencing deals and/or other financing arrangements) to complete existing pre-clinical develop...
- Geoffroy Michalet
Wendel : Q1 NAV: € 178.1/share, +11% YTD, driven by BVI, and a little ...
>Q1 NAV: € 178.1m/share, good growth level - Wendel reported Q1 2024 NAV of € 178.1, up vs end-2023 (€ 160.2). In detail, the valuation of listed holdings rose by 20% (+€ 0.7bn, including +€ 0.8bn for BVI and -€ 0.1bn for IHS). The valuation of unlisted companies is up very slightly by 2% (with Stahl and CPI well oriented, unlike Acams and Scalian). The LTV remains very controlled, at -5.1% pro forma for the sale of the BVI block (€ 1.1bn) and the dividend paid b...
- Martin Marandon-Carlhian
- Stephane Houri
ams OSRAM : Q1 2024 results in line, Q2 guidance below expectations, i...
>Q1 2024 results globally in line with expectations but above on FCF - This morning, ams OSRAM reported its Q1 2024 results which were globally in line with expectations. Revenues were € 847m, in line with the Visible Alpha consensus at € 845m. They were down 7% q-o-q and down 9% y-o-y but up 5% y-o-y on a like-for-like basis. The main drivers for this year-on-year increase are the automotive (+13% y-o-y) and consumer (+15% y-o-y) semiconductor businesses, whilst indu...
- Bert Colijn
Eurozone bank lending continues to cautiously recover
The European Central Bank is on the verge of starting rate cuts and monetary developments are proving no hurdle to doing so. March data shows a subdued recovery in bank lending and money growth. With inflation expectations falling further, today's data is in line with a start to cautious rate cuts
- Martin Marandon-Carlhian
- Stephane Houri
ams OSRAM : Q1 2024 results in line, Q2 guidance below expectations, i...
>Q1 2024 results globally in line with expectations but above on FCF - This morning, ams OSRAM reported its Q1 2024 results which were globally in line with expectations. Revenues were € 847m, in line with the Visible Alpha consensus at € 845m. They were down 7% q-o-q and down 9% y-o-y but up 5% y-o-y on a like-for-like basis. The main drivers for this year-on-year increase are the automotive (+13% y-o-y) and consumer (+15% y-o-y) semiconductor businesses, whilst indu...
- Fatma Agnès Hamdani
Savencia SA : Q1 weaker than expected. Flat organic growth
>Q1 sales of € 1,696m up 1.6% and flat on an organic basis at +0.1%. Organic growth is adjusted for the hyperinflation situation in Argentina - Q1 sales rose slightly by 1.6% to € 1,696m. This is well below our estimate of € 1,832.1m. Organic growth was flat at 0.1% vs 11.5% expected. The growth differential concerns in particular other dairy products. The division reported sales of € 762m, up 2.1% and down -2.1% in organic terms (vs +23.2% in Q1 and +23.8% in Q4 2023...
- Gerardo Ibanez
- Steven Boumans
Cofinimmo : Q1 2024 results: Inline results, with a reiterated outlook...
>Outlook reiterated, inline results, underlying metrics look good - Outlook FY2024 Net result from core activities reiterated at €6.40 and €6.20 DPS.Like-for-like devaluations of -€46m or -0.7% (FY 2023: -2.7%).Healthcare operator performance is improving, with underlying occupancy being strong at >90% for all countries with the exception of Germany (84%) from the data collected.Gross rental income up +2.2% on a like-for-like basis (vs FY2023: +5.5% and...
- Wim Gille
Signify : Weak first quarter, but momentum picking up.
>A weak first quarter - The company is in the process of restructuring its internal business lines / reporting and hence we only have results on group level and limited disclosure on business unit level for this quarter as previously announced. Group revenues fell 4,9% short of expectations as the comparable sales growth (CSG) came in at minus 10,1% vs minus 7,3% expected. On a sequential basis CSG in Professional deteriorated from -2,9% in 4Q23 to -7,6% in 1Q24, larg...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.